Sivik Global Healthcare’s AbbVie ABBV Stock Holding History

Sivik Global Healthcare’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.26M	Hold	15,000	–	–	2.48%	22
2026 Q1	$3.26M	Sell	15,000 -5,000	-25%	-$1.11M	2.48%	22
2025 Q4	$4.57M	Hold	20,000	–	–	1.33%	25
2025 Q3	$4.63M	Buy	+20,000	New	+$4.07M	1.35%	30
2025 Q1	–	Sell	-25,000	Closed	-$4.44M	–	32
2024 Q4	$4.44M	Buy	+25,000	New	+$4.6M	2.34%	20
2023 Q2	–	Sell	-40,000	Closed	-$6.38M	–	45
2023 Q1	$6.38M	Buy	+40,000	New	+$6.12M	2.74%	15
2022 Q2	–	Sell	-20,000	Closed	-$3.24M	–	39
2022 Q1	$3.24M	Sell	20,000 -20,000	-50%	-$2.91M	1.34%	35
2021 Q4	$5.42M	Buy	+40,000	New	+$4.73M	2.32%	20
2021 Q3	–	Sell	-20,000	Closed	-$2.25M	–	45
2021 Q2	$2.25M	Buy	+20,000	New	+$2.25M	0.44%	43
2020 Q3	–	Sell	-13,000	Closed	-$5.87M	–	39
2020 Q2	$5.87M	Buy	13,000 +3,000	+30%	+$264K	1.94%	21
2020 Q1	$3.51M	Sell	10,000 -40,000	-80%	-$3.41M	1.38%	34
2019 Q4	$4.43M	Buy	+50,000	New	+$4.15M	1.64%	33
2019 Q2	–	Sell	-42,500	Closed	-$3.42M	–	61
2019 Q1	$3.42M	Buy	+42,500	New	+$3.48M	1.26%	38
2018 Q2	–	Sell	-75,000	Closed	-$7.1M	–	62
2018 Q1	$7.1M	Buy	75,000 +10,000	+15%	+$1.1M	3.31%	4
2017 Q4	$6.29M	Sell	65,000 -30,000	-32%	-$2.83M	2.33%	13
2017 Q3	$8.44M	Buy	95,000 +35,000	+58%	+$2.66M	2.87%	5
2017 Q2	$4.35M	Buy	+60,000	New	+$4.03M	1.59%	28
2016 Q4	–	Sell	-55,000	Closed	-$3.47M	–	55
2016 Q3	$3.47M	Buy	+55,000	New	+$3.56M	1.75%	28
2014 Q4	–	Sell	-40,000	Closed	-$2.31M	–	65
2014 Q3	$2.31M	Sell	40,000 -45,000	-53%	-$2.5M	1.05%	48
2014 Q2	$4.8M	Buy	85,000 +26,640	+46%	+$1.4M	2.42%	12
2014 Q1	$3M	Sell	58,360 -1,640	-3%	-$82.9K	1.87%	21
2013 Q4	$3.17M	Buy	+60,000	New	+$2.95M	2.25%	15

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Sivik Global Healthcare's ABBV Position: Q2 2026 in Review

Sivik Global Healthcare held its AbbVie (ABBV) position steady in Q2 2026 at 15,000 shares worth $3.26M. The position accounts for 2.48% of the portfolio, ranked #22.

Sivik Global Healthcare first reported a position in ABBV in Q4 2013 and has held it in 22 quarters since. The position peaked at $8.44M in Q3 2017. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Sivik Global Healthcare held 15,000 shares of AbbVie worth $3.26M as of Q2 2026.
Sivik Global Healthcare left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 2.48% of Sivik Global Healthcare's portfolio in Q2 2026, its #22 holding.
Sivik Global Healthcare first reported a position in AbbVie in Q4 2013 and has held it in 22 quarters since.
Sivik Global Healthcare's AbbVie position peaked at $8.44M in Q3 2017.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.